Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction

Journal of the American College of Cardiology

Volumn 27, Issue 7, 1996, Pages 1656-1661

  Arakawa, Naoshi ^a   Nakamura, Motoyuki ^a   Aoki, Hidehiko ^a   Hiramori, Katsuhiko ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; FEMALE; HEART DEATH; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

EID: 0029979053     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(96)00067-8     Document Type: Article

References (49)

1. McGregor A, Richards M, Espiner E, Yandle T, Ikram H. Brain natriuretic peptide administered to man: actions and metabolism. J Clin Endocrinol Metab 1990;70:1103-7.
2. Holmes SJ, Espiner EA, Richards AM, Yandle TG, Frampton C. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab 1993;76:91-6.
3. Richards AM, Nicholls MG, Ikram H, Webster MWI, Yandle TG, Espiner EA. Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet 1985;1:545-9.
4. Richards AM, Tonolo G, Montorsi P, et al. Low dose infusions of 26- and 28-amino acid human atrial natriuretic peptides in normal man. J Clin Endocrinol Metab 1988;66:465-72.
5. Yoshimura M, Yasue H, Morita E, et al. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 1991;84:1581-8.
6. Richards AM, Crozier IG, Holmes SJ, Espiner EA, Yandle TG, Frampton C. Brain natriuretic peptide: natriuretic and endocrine effects in essential hypertension. J Hypertens 1993;11:163-70.
7. Saito Y, Nakao K, Nishimura K, et al. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation 1987;76:115-24.
8. Crozier IG, Ikram H, Gomez HJ, Nicholls MG, Espiner EA, Warner NJ. Haemodynamic effects of atrial natriuretic peptide infusion in heart failure. Lancet 1986;ii:1242-5.
9. Molina CR, Fowler MB, McCrory S, et al. Hemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failure. J Am Coll Cardiol 1988;12:175-86.
10. Nakamura M, Arakawa N, Kato M. Renal, hormonal, and hemodynamic effects of low-dose infusion of atrial natriuretic factor in acute myocardial infarction. Am Heart J 1990;120:1078-85.
11. Hosoda K, Nakao K, Mukoyama M, et al. Expression of brain natriuretic peptide gene in human heart: production in the ventricle. Hypertension 1991;17:1152-6.
12. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991;87:1402-12.
13. Ogawa Y, Nakao K, Mukoyama M, et al. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats: the ventricles are a major site of synthesis and secretion of brain natriuretic peptide. Circ Res 1991;69:491-500.
14. de Bold AJ. Atrial natriuretic factor: a hormone produced by the heart. Science 1985;230:767-70.
15. Sugawara A, Nakao K, Morii N, et al. alpha-Human atrial natriuretic polypeptide is released from the heart and circulation in the body. Biochem Biophys Res Commun 1985;129:439-46.
16. Nakayama K, Ohkubo H, Hirose T, Inayama S, Nakanishi S. mRNA sequence for human cardiodilation-atrial natriuretic factor precursor and regulation of precursor mRNA in rat atria. Nature 1984;310:699-701.
17. Mukoyama M, Nakao K, Saito Y, et al. Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 1990;313:757-8.
18. Wei CM, Heublein DM, Perrella MA, et al. Natriuretic peptide system in human heart failure. Circulation 1993;88:1004-9.
19. Raine AEG, Erne P, Burgisser E, et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 1986;315: 533-7.
20. Burnett JC, Kao PC, Hu DC, et al. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 1986;231:1145-7.
21. Yoshimura M, Yasue H, Okumura K, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993;87:464-9.
22. Richards AM, Crozier IG, Yandle TG, Espiner EA, Ikram H, Nicholls MG. Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease. Br Heart J 1993;69:414-7.
23. Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203.
24. Choy AMJ, Darbar D, Lang CC, et al. Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods. Br Heart J 1994;72:16-22.
25. Mukoyama M, Nakao K, Obata K, et al. Augmented secretion of brain natriuretic peptide in acute myocardial infarction. Biochem Biophys Res Commun 1991;180:431-6.
26. Morita E, Yasue H, Yoshimura M, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993;88:82-91.
27. White HD, Norris RM, Brown MA, Brandt PWT, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
28. Nicod P, Gilpin E, Dittrich H, et al. Influence on prognosis and morbidity of left ventricular ejection fraction with and without signs of left ventricular failure after acute myocardial infarction. Am J Cardiol 1988;61:1165-71.
29. Svanegaard J, Angelo-Nielsen K, Pindborg T. Plasma concentration of atrial natriuretic peptide at admission and risk of cardiac death in patients with acute myocardial infarction. Br Heart J 1992;68:38-42.
30. Omland T, Aarsland T, Aakvaag A, Lie RT, Dickstein K. Prognostic value of plasma atrial natriuretic factor, norepinephrine and epinephrine in acute myocardial infarction. Am J Cardiol 1993;72:255-9.
31. Nakamura M, Arakawa N, Yoshida H, et al. Prognostic implication of plasma levels of atrial natriuretic factor in patients with acute myocardial infarction. Intern Med 1993;32:112-5.
32. Omland T, Bonarjee VVS, Nilsen DWT, et al. Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with atrial natriuretic factor (99-126) and clinical evaluation. Br Heart J 1993;70:409-14.
33. Arakawa N, Nakamura M, Aoki H, Hiramori K. Relationship between plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology 1994;85:334-40.
34. Nakamura M, Kawata Y, Yoshida H, et al. Relationship between plasma atrial and brain natriuretic peptide concentration and hemodynamic parameters during percutaneous transvenous mitral valvulotomy in patients with mitral stenosis. Am Heart J 1992;124:1283-8.
35. Motwani JG, McAlpine H, Kennedy N, Struthers AD. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction. Lancet 1993;341:1109-13.
36. Bates ER, Shenker Y, Grekin RJ. The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man. Circulation 1986;73:1155-61.
37. Tomoda H. Atrial natriuretic peptide in acute myocardial infarction. Am J Cardiol 1988;62:1122-3.
38. Horio T, Shimada K, Kohno M, et al. Serial changes in atrial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplasty. Am Heart J 1993;126:293-9.
39. Nakamura M, Yoshida H, Arakawa N, Aoki H, Chiba M, Hiramori K. Plasma atrial natriuretic factor in patients with acute myocardial infarction. Jpn Heart J 1992;33:619-29.
40. Tan ACITL, van Loenhout TT, Lamfers EJP, Hooghoudt TEH, Kloppenborg PWC, Benraad TJ. Atrial natriuretic peptide after myocardial infarction. Am Heart J 1989;118:490-4.
41. Ngo L, Vesely DL, Bissett JK, et al. Acute and sustained release of atrial natriuretic factor with acute myocardial infarction. Am Heart J 1989;118: 893-900.
42. Wencker M, Lechleitner P, Dienstl F, Hauptlorenz S, Puschendorf B. Early decrease in atrial natriuretic peptide in acute myocardial infarction. Lancet 1987;1:1369.
43. Crozier IG, Ikram H, Nicholls MG, Espiner EA, Yandle TG. Atrial natriuretic peptide in spontaneous tachycardias. Br Heart J 1987;58:96-100.
44. Phillips PA, Sasadeus J, Hodsman GP, Horowitz J, Saltups A, Johnston CI. Plasma atrial natriuretic peptide in patients with acute myocardial infarction: effects of streptokinase. Br Heart J 1989;61:139-43.
45. Naruse M, Higashida T, Naruse K, et al. Coronary hemodynamics and cardiac beating modulate atrial natriuretic factor release from isolated Langendorff-perfused rat hearts. Life Sci 1987;41:421-7.
46. Kinnunen P, Vuolteenano O, Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium effect of stretching. Endocrinology 1993;132:1961-70.
47. Hasegawa K, Fujiwara H, Doyama K, et al. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation 1993;88: 372-80.
48. Toth M, Vuorinen KH, Vuolteenaho O, et al. Hypoxia stimulates release of atrial natriuretic peptide and BNP from perfused rat ventricular myocardium. Am J Physiol 1994;266:H1572-80.
49. Hama N, Itoh H, Shirakami G, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 1995;92:1588-64.